What are you searching for?

Sign in

SNN Initiates Voluntary Recall of Optional Hip Liner

Company not pleased with clinical results.

Smith & Nephew plc has initiated a voluntary market withdrawal of the optional metal liner component of its R3 Acetabular System. According to the company, this does not impact other R3 System liners.

Company officials added that the move does not change the current practice for patient follow-up care for this component.

Andy Weymann, M.D., Smith & Nephew’s Chief Medical Officer, said: “We regularly review the effectiveness of our products and are not satisfied with the clinical results of this component. As with all medical devices, anyone experiencing unusual symptoms should contact their surgeon.”

Approximately 7,700 metal liners have been implanted since the component was introduced in 2007 and launched globally in 2009. The majority of these have been used in stemmed total hip replacements, according to the company.

In 2011, procedures using this component accounted for less than 1 percent of Smith & Nephew’s global hip implant revenue.

London, United Kingdom-based Smith & Nephew had annual sales in 2011 of nearly $4.3 billion.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters